A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
Conditions
Heterozygous Familial Hypercholesterolemia (HeFH)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Nemours/Alfred I. duPont Hospital for Children ( Site 0001), Wilmington, Delaware, United States
Children's National Medical Center ( Site 0015), Washington D.C., District of Columbia, United States
Excel Medical Clinical Trials ( Site 0008), Boca Raton, Florida, United States
Children's Healthcare of Atlanta Cardiology ( Site 0026), Atlanta, Georgia, United States
Cincinnati Children's Hospital Medical Center ( Site 0016), Cincinnati, Ohio, United States
West Virginia University ( Site 0013), Morgantown, West Virginia, United States
Monash Children s Hospital ( Site 1603), Clayton, Victoria, Australia
UZ Antwerpen ( Site 0601), Edegem, Antwerpen, Belgium
Universidade Federal Do Ceara ( Site 0201), Fortaleza, Ceará, Brazil
Incor - Instituto do Coracao ( Site 0200), São Paulo, Brazil
Explora Salud ( Site 0304), Santiago, Region M. de Santiago, Chile
Pontificia Universidad Catolica de Chile ( Site 0300), Santiago, Region M. de Santiago, Chile
Beijing Anzhen Hospital. Capital Medical University ( Site 1917), Beijing, Beijing Municipality, China
Shanghai Children's Medical Center ( Site 1918), Shanghai, Shanghai Municipality, China
The Children's Hospital of Zhejiang University School of Medicine ( Site 1905), Hangzhou, Zhejiang, China
Clinica de la Costa S.A.S. ( Site 0400), Barranquilla, Atlántico, Colombia
Oncomédica S.A.S ( Site 0401), Montería, Departamento de Córdoba, Colombia
Fundación Cardiovascular de Colombia ( Site 0402), Piedecuesta, Santander Department, Colombia
Fundacion Valle del Lili ( Site 0403), Cali, Valle del Cauca Department, Colombia
New Childrens Hospital ( Site 0800), Helsinki, Uusimaa, Finland
Universitaetsklinikum Freiburg ( Site 2203), Freiburg im Breisgau, Baden-Wurttemberg, Germany
Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" ( Site 0501), Monterrey, Nuevo León, Mexico
Centro de Investigacion Clinica de Oaxaca ( Site 0505), Oaxaca City, Oaxaca, Mexico
INVECORDIS S.C. ( Site 0503), Huixquilucan, Mexico
Amsterdam UMC, locatie AMC ( Site 1000), Amsterdam, North Holland, Netherlands
New Zealand Clinical Research (Christchurch) ( Site 1700), Christchurch, Canterbury, New Zealand
National University Hospital-Paediatrics ( Site 1800), Singapore, Central Singapore, Singapore
Hospital Universitario Central de Asturias ( Site 1303), Oviedo, Asturias, Principado de, Spain
Hospital Clinico Universitario de Santiago de Compostela ( Site 1300), Santiago de Compostela, La Coruna, Spain
COMPLEJO HOSPITALARIO DE NAVARRA ( Site 1302), Pamplona, Navarre, Spain
Birmingham Childrens Hospital ( Site 1501), Birmingham, United Kingdom
Sheffield Childrens Hospital ( Site 1503), Sheffield, United Kingdom
Southampton General Hospital ( Site 1502), Southampton, United Kingdom
Study leads
Medical Director
Study Director
Merck Sharp & Dohme LLC